Madison Air Solutions Beats Q3 2026 Estimates
Revenue of $1.13B vs. $1.06B expected and adjusted EPS of $0.38 vs. $0.29.
Madison Air Solutions (MAIR) beat estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $1.13 billion above the $1.06 billion estimate, and adjusted EPS was $0.38 above the $0.29 estimate.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $0.29 | $0.38 | Beat by 30% |
| Revenue | $1.06B | $1.13B | Beat by 6.5% |
| Change | QoQ |
|---|---|
| Adjusted EPS | ▲ 23% |
| Revenue | ▲ 14% |
By our calculation, revenue was $69.2 million above the estimate and adjusted EPS was $0.09 above it. The QoQ column compares with the previous quarter's revenue of $991.3 million and adjusted EPS of $0.31.
Track record
- EPS record. Adjusted EPS beat the estimate in 3 of the last 3 reports, including this one.
- Revenue record. Revenue beat the estimate in 3 of the last 3 reports.
- Revenue trend. Revenue over the last 3 reports, oldest first: $923.7 million, $991.3 million and $1.13 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.27 and revenue of $1.03 billion next quarter, based on 7 analysts.
- Estimate record. Whether Madison Air Solutions extends a record of beating EPS estimates in 3 of its last 3 reports.
- Sequential trend. Whether revenue builds on its 14% increase from the previous quarter.
- Related coverage. See our reports on Resolute Holdings Management, Lantheus, Keel Infrastructure and Iovance Biotherapeutics.
Sources: Results are from Madison Air Solutions's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Madison Air Solutions's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Resolute Holdings Management Q3 2026 Revenue Rises 322% to $509.6M
EarningsLantheus Beats Q3 2026 Estimates as Revenue Rises 1.5% to $389.9M
EarningsKeel Infrastructure Q3 2026 Revenue Tops Estimates at $27.6M, but EPS Misses at -$0.10
EarningsIovance Biotherapeutics Beats Q3 2026 Estimates as Revenue Rises 80% to $121.5M
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.